Bay1002670, Fibroids, Safety and Efficacy EU,US,Can, Jap
Public ClinicalTrials.gov record NCT02131662. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Parallel-group, Double-blind, Placebo Controlled, Multi-center Study to Assess the Efficacy and Safety of Different Doses of BAY1002670 in Subjects With Uterine Fibroids Over 3 Months
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The study is performed to assess the efficacy and safety of different doses of BAY1002670 in subjects with uterine fibroids. The dose-response relationship will be evaluated. Further, the study aims to establish a population pharmacokinetic/pharmacodynamic relationship for BAY1002670 in subjects with uterine fibroids. To assess the efficacy of BAY1002670 the interchangeability of menstrual pictogram and alkaline hematin method for the judgement of menstrual blood loss will be assessed.
Study identification
- NCT ID
- NCT02131662
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 309 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 50 Years
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 15, 2014 (Actual)
- Primary completion
- May 4, 2016 (Actual)
- Completion
- May 4, 2016 (Actual)
- Last update posted
- Dec 8, 2017
2014 – 2016
United States locations
- U.S. sites
- 36
- U.S. states
- 21
- U.S. cities
- 32
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Mesa | Arizona | 85209 | — |
| Not listed | Tucson | Arizona | 85712 | — |
| Not listed | San Diego | California | 92103 | — |
| Not listed | San Diego | California | 92108 | — |
| Not listed | Denver | Colorado | 80209 | — |
| Not listed | Southington | Connecticut | 06489 | — |
| Not listed | Washington D.C. | District of Columbia | 20036 | — |
| Not listed | Gainesville | Florida | 32606 | — |
| Not listed | Jacksonville | Florida | 32207 | — |
| Not listed | Plantation | Florida | 33324 | — |
| Not listed | South Miami | Florida | 33143 | — |
| Not listed | Sandy Springs | Georgia | 30328 | — |
| Not listed | Naperville | Illinois | 60540 | — |
| Not listed | Newburgh | Indiana | 47630 | — |
| Not listed | Marrero | Louisiana | 70072 | — |
| Not listed | Lincoln | Nebraska | 68510 | — |
| Not listed | Moorestown | New Jersey | 08057 | — |
| Not listed | Neptune City | New Jersey | 07753 | — |
| Not listed | New Brunswick | New Jersey | 08901 | — |
| Not listed | New York | New York | 10038 | — |
| Not listed | Durham | North Carolina | 27713 | — |
| Not listed | Raleigh | North Carolina | 27612 | — |
| Not listed | Cleveland | Ohio | 44195 | — |
| Not listed | Columbus | Ohio | 43231 | — |
| Not listed | Portland | Oregon | 97239-3011 | — |
| Not listed | Philadelphia | Pennsylvania | 19104 | — |
| Not listed | Philadelphia | Pennsylvania | 19114 | — |
| Not listed | Pittsburgh | Pennsylvania | 15206 | — |
| Not listed | Pittsburgh | Pennsylvania | 15213-3180 | — |
| Not listed | Chattanooga | Tennessee | 37404 | — |
| Not listed | Dallas | Texas | 75231 | — |
| Not listed | Frisco | Texas | 75035 | — |
| Not listed | Houston | Texas | 77030 | — |
| Not listed | Houston | Texas | 77054 | — |
| Not listed | Norfolk | Virginia | 23507 | — |
| Not listed | Seattle | Washington | 98105 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 69 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02131662, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 8, 2017 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02131662 live on ClinicalTrials.gov.